Carevive SMART Data – EVALUATE

Through the Carevive digital oncology platform, utilized by cancer centers across the US, we gather patient experience data directly from those battling breast cancer, lung cancer, multiple myeloma, ovarian cancer, and AML. This data collection aims to address three crucial questions: Firstly, the feasibility of gathering real-world patient experience data in routine care settings. Secondly, the invaluable trends that longitudinal real-world data sets can reveal about the patient experience. Lastly, how digital tools empower clinicians to predict and manage the experiences of cancer patients more effectively.

With a comprehensive approach, Carevive is transforming cancer care by harnessing the power of patient experience insights. Join us on this transformative journey as we continue to make a positive impact on the lives of cancer patients and their healthcare providers. Together, we build a brighter future for cancer care, one step at a time.

Recent Episodes

The rising cost of healthcare continues to strain employers and employees alike. With premiums climbing at a rate outpacing inflation, many organizations are burdened with high costs and subpar outcomes. Employer-built healthcare models are emerging as a potential solution, enabling organizations to take control of their healthcare systems. According to the Kaiser Family Foundation,…

Women’s health remains a critical issue globally, with alarming disparities in access and outcomes. A new survey from Hologic and Gallup reveals that while nearly 90% of women recognize the importance of health screenings, less than half undergo them consistently due to barriers like cost, time, and anxiety. The stakes are particularly high in…

Behavioral health challenges have intensified nationwide, with wait times for care stretching months and access in rural areas remaining inadequate. Telehealth innovations are emerging as a crucial bridge to close these gaps, particularly in behavioral health. The stakes are high and according to the 2023 National Survey on Drug Use and Health (NSDUH), 22.8%…